InVivoSIM anti-human CD79b (Polatuzumab Biosimilar)

Catalog #SIM0060
Clone:
Polatuzumab
Reactivities:
Human

$235.00 - $8,140.00

$235.00 - $8,140.00

Choose an Option...
  • 100 mg - $8,140.00
  • 50 mg - $4,574.00
  • 25 mg - $3,182.00
  • 5 mg - $911.00
  • 1 mg - $235.00
  • Custom Amount (Quotes Only)
In stock
Only %1 left

Product Details

This non-therapeutic biosimilar antibody uses the same variable regions as the therapeutic antibody Polatuzumab, making it ideal for research use. Polatuzumab is a humanized IgG1 monoclonal antibody that targets CD79b, a critical component of the B cell receptor (BCR) complex. CD79b, also known as Igβ, forms a heterodimer with CD79a (Igα) and is essential for signal transduction following antigen engagement of surface immunoglobulin. The CD79a/CD79b complex initiates downstream signaling cascades that regulate B cell development, activation, proliferation, and survival. CD79b is expressed throughout most stages of B cell maturation but is absent from plasma cells and non-B lineage cells. Importantly, CD79b is retained on the surface of many malignant B cells, including those in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma, making it an attractive therapeutic and diagnostic target. Polatuzumab serves as the antibody backbone for the FDA-approved antibody-drug conjugate Polatuzumab vedotin, which delivers a cytotoxic MMAE payload to CD79b+ cells. In contrast, this unconjugated biosimilar form lacks any drug conjugation, allowing researchers to study CD79b-specific antibody binding, internalization, and function without the confounding effects of cytotoxicity. This Polatuzumab biosimilar antibody retains the antigen-binding domains of the therapeutic but is produced for non-clinical research use. It is suitable for a range of applications, including flow cytometry, B cell targeting studies, preclinical modeling, and ADC development.

Specifications

Isotype Human IgG1, Īŗ
Recommended Isotype Control(s) RecombiMAb human IgG1 isotype control, anti-hen egg lysozyme
Recommended Dilution Buffer InVivoPure pH 7.0 Dilution Buffer
Immunogen Human CD79b
Reported Applications Functional assays
Flow cytometry
Immunoprecipitation
ELISA
Formulation PBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin <0.5EU/mg (<0.0005EU/μg)
Determined by LAL gel clotting assay
Aggregation <5%
Determined by SEC
Purity >95%
Determined by SDS-PAGE
Sterility 0.2 µm filtration
Production Purified from cell culture supernatant in an animal-free facility
Purification Protein A
Molecular Weight 150 kDa
Murine Pathogen Tests Ectromelia/Mousepox Virus: Negative
Hantavirus: Negative
K Virus: Negative
Lactate Dehydrogenase-Elevating Virus: Negative
Lymphocytic Choriomeningitis virus: Negative
Mouse Adenovirus: Negative
Mouse Cytomegalovirus: Negative
Mouse Hepatitis Virus: Negative
Mouse Minute Virus: Negative
Mouse Norovirus: Negative
Mouse Parvovirus: Negative
Mouse Rotavirus: Negative
Mycoplasma Pulmonis: Negative
Pneumonia Virus of Mice: Negative
Polyoma Virus: Negative
Reovirus Screen: Negative
Sendai Virus: Negative
Theiler’s Murine Encephalomyelitis: Negative
Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.